Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
VERTEX PHARMACEUTICALS, INC.
Vertex Pharmaceuticals, Inc.
XNAS: VRTX
Mid-range Performer
Download real time
499.17
0.00
(
0.00
%)
Near 52W High of $519.68
2,659.3
XNAS Volume
XNAS
11 Mar, 2026 9:29 AM (EDT)
Watchlist
Portfolio
Alert
My Notes
Board Meeting
The board meeting for Vertex Pharma is scheduled for today, for the purpose of Barclays 28th Annual Global Healthcare Conference
See details
Overview
Buy Sell Zone
Financials
Technicals
Price History/Seasonality
Ownership
Politician Trades
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Vertex Pharma - VRTX - stock price prediction, stock price target, analyst ratings from 32 analysts
Vertex Pharma has a share price target of US$ 546, revenue growth forecast of 8.6%, and profit growth estimate of 13.7% for FY26, based on top 32 analyst calls.
Forecaster Screeners